1.
|
Phase: Phase III Type: Diagnostic Status: Completed Age: Not specified Sponsor: Other Protocol IDs: MBG308, NCT00126412
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MIP-IB12, NCT00458952
|
|
3.
|
Phase: Phase II Type: Treatment Status: Closed Age: Child Sponsor: Other Protocol IDs: NCRR-M01RR00240-1748, NCT00013806
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 to 70 Sponsor: NICHD Protocol IDs: 020032, 02-CH-0032, NCT00028106
|
|
5.
|
Phase: Phase II Type: Treatment Status: Closed Age: 1 to 29 Sponsor: NCI, Other Protocol IDs: CDR0000450148, P01CA081403, N2001-02, NANT-2001-02, NCT00253435
|
|
6.
|
Phase: Phase II Type: Treatment Status: Closed Age: 12 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MIP-IB12B, NCT00874614
|
|
7.
|
Phase: Phase I Type: Treatment Status: Completed Age: 1 to 21 (1 to 20 at diagnosis) Sponsor: NCI, Other Protocol IDs: CDR0000067966, P01CA081403, N99-01, NANT-99-01, CHLA-LA-NANT-99-01, NCI-V00-1592, NCT00005978
|
|
8.
|
Phase: Phase I Type: Treatment Status: Completed Age: 1 to 30 Sponsor: NCI, Other Protocol IDs: CDR0000363631, P01CA081403, N2000-01, NANT-2000-01, NCT00083135
|
|
9.
|
Phase: Phase I Type: Treatment Status: Closed Age: 1 to 30 Sponsor: NCI, Other Protocol IDs: CDR0000558042, P01CA081403, N2004-06, NANT-Draximage-2007-01, NANT-2004-06, NANT N2004-06, NANT-N04-06, NCT00509353
|